Unum Group

UNMA ·Financial, Insurance - Health, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $13.08B $12.89B $12.39B $11.98B $12.01B $13.16B $12.00B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income $933.5M $2.25B $1.64B $1.75B $1.26B $964.0M $1.38B
Operating Margin 7.1% 17.5% 13.2% 14.6% 10.5% 7.3% 11.5%
Interest Expense
Pretax Income $933.5M $2.25B $1.64B $1.75B $1.26B $964.0M $1.38B
Income Tax Expense $195.0M $472.2M $356.3M $342.8M $279.6M $171.0M $281.8M
Net Income $738.5M $1.78B $1.28B $1.41B $981.0M $793.0M $1.10B
Net Margin 5.6% 13.8% 10.4% 11.7% 8.2% 6.0% 9.2%
EPS (Basic) $4.28 $9.49 $6.53 $7.01 $4.80 $3.89 $5.25
EPS (Diluted) $4.27 $9.46 $6.50 $6.96 $4.79 $3.89 $5.24
Shares Outstanding (Basic) 163.8M 172.5M 187.5M 196.7M 200.6M 204.2M 203.6M 209.7M
Shares Outstanding (Diluted) 163.8M 172.9M 188.1M 197.6M 202.1M 204.8M 203.8M 209.9M
Dividends Per Share $1.76 $1.57 $1.39 $1.26 $1.17 $1.14 $1.09
← Newer Page 1 of 3 Older →